PUBLISHED-SEQUENCE ANTIBODY · SC-PSA-0162

Suciraslimab antibody

CD22 / SIGLEC2

Available by inquiry

Suciraslimab is a research antibody reference targeting CD22 / SIGLEC2. Pure and fluorescently conjugated formats are available by inquiry.

Catalog number
SC-PSA-0162
Target
CD22 / SIGLEC2
Available formats
Pure or fluorescently conjugated
Research use
For research use only

Product information

Available labeling options

Pure · Biotin · BV421 · V450 · V500 · AF488 · PerCP-Cy5.5 · PE · AF594 · PE-Cy5 · PE-Cy7 · APC · AF700 · APC-Cy7

Tell us the intended application, amount and preferred label. Final configuration and delivery are confirmed in the quotation.

PUBLIC REFERENCE

Reference source

WHO Recommended INN List 87 (2022)

View reference ↗
START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact us
Suciraslimab Antibody (CD22 / SIGLEC2) | StellaCyte